Atopic Dermatitis

Inflammatory ICD: L20

Also known as: Eczema, Atopic Eczema

Description

Atopic dermatitis is a chronic, relapsing inflammatory skin disease characterised by intense pruritus and eczematous lesions. It is the most common inflammatory skin disease in children but frequently persists into adulthood. It is associated with a defective epidermal barrier (filaggrin mutations) and immune dysregulation (Th2 skewing).

Symptoms

  • Intense pruritus (hallmark symptom)
  • Erythematous, oedematous patches and plaques
  • Xerosis (dry skin)
  • Excoriations from scratching
  • Lichenification in chronic cases
  • Flexural distribution in older children and adults

Causes & Triggers

  • Genetic barrier defects (filaggrin mutations)
  • Immune dysregulation (Th2-dominant response)
  • Environmental triggers (allergens, irritants)
  • Stress and weather changes
  • Microbial colonisation (Staphylococcus aureus)

Severity Classification

Mild Dry skin with infrequent itching, minimal impact on daily activities
Moderate Frequent itching, visible eczematous lesions, disturbed sleep
Severe Widespread inflammation, constant itching, significant quality-of-life impairment

Treatment Ladder

  1. 1 Foundational: Emollient therapy — liberal use of fragrance-free moisturisers
  2. 2 Mild: Low-potency topical corticosteroids (hydrocortisone 1%)
  3. 3 Moderate: Medium-potency topical corticosteroids + calcineurin inhibitors for steroid-sparing
  4. 4 Severe: Short courses of potent topical steroids, phototherapy
  5. 5 Refractory: Systemic immunomodulators (dupilumab, JAK inhibitors)

Relevant Compounds

Recommended Drugs

Suggested Cosmetics

Lifestyle Tips

  • Moisturise liberally and frequently — within 3 minutes of bathing
  • Use lukewarm water for bathing — avoid hot showers
  • Wear soft, breathable fabrics (cotton) — avoid wool
  • Identify and avoid personal triggers (dust mites, certain detergents)
  • Keep nails short to minimise excoriation damage
  • Consider wet wrap therapy during severe flares

When to Refer

  • Severe or widespread disease not controlled with topical therapy
  • Need for systemic immunomodulators or biologics
  • Suspected eczema herpeticum (urgent referral)
  • Recurrent secondary infections
  • Significant impact on sleep, work, or mental health